Introduction: Schizoaffective disorder (SA) is classified into bipolar (bSA) and depressive (dSA) subtypes. Although clinical differences between both have been reported, there is no clear information regarding their specific cognitive profile. Objective: To compare neurocognition between SA subtypes and schizophrenia (SC). Methods: A total of 61 patients were assessed and divided into 3 groups: 35 SC, 16 bSA, and 10 dSA. All participants signed an informed consent letter. The MATRICS Consensus Cognitive Battery, Central and South American version was used to assess neurocognition. The study was performed at the Instituto Nacional de Psiquiatría “Ramón de la Fuente”. Participants were identified by specialized psychiatrists. Trained neuropsychologists carried out the clinical and cognitive assessment, which lasted 2 h approximately. Results: The cognitive assessment showed a significant difference in Trail Making Test part A subtest (F[2,58] = 4.043; p = 0.023]. Post hoc analyses indicated that dSA obtained a significantly higher score than SC (MD = –11.523; p = 0.018). The f test showed a large effect size (f = 0.401). No statistical differences were observed regarding other cognitive variables. Conclusions: The cognitive profile of SA subtypes and SC is similar since no differences were found in most subtests. However, dSA may be less impaired than SC in measures of processing speed. Further research with larger samples must be conducted.

1.
American Psychiatric Association
.
Diagnostic and Statistical Manual of Mental Disorders DSM-5
. 5th ed.
Madrid
:
Panamericana
;
2013
.
2.
Cheniaux
E
,
Landeira-Fernandez
J
,
Lessa Telles
L
,
Lessa
JL
,
Dias
A
,
Duncan
T
, et al
Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders
.
J Affect Disord
.
2008
Mar
;
106
(
3
):
209
17
.
[PubMed]
0165-0327
3.
Peralta
V
,
Cuesta
MJ
.
Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach
.
J Affect Disord
.
2008
May
;
108
(
1-2
):
71
86
.
[PubMed]
0165-0327
4.
Wilson
JE
,
Nian
H
,
Heckers
S
.
The schizoaffective disorder diagnosis: a conundrum in the clinical setting
.
Eur Arch Psychiatry Clin Neurosci
.
2014
Feb
;
264
(
1
):
29
34
.
[PubMed]
0940-1334
5.
Rink
L
,
Pagel
T
,
Franklin
J
,
Baethge
C
.
Characteristics and heterogeneity of schizoaffective disorder compared with unipolar depression and schizophrenia - a systematic literature review and meta-analysis
.
J Affect Disord
.
2016
Feb
;
191
:
8
14
.
[PubMed]
0165-0327
6.
Marneros
A
.
The schizoaffective phenomenon: the state of the art
.
Acta Psychiatr Scand Suppl
.
2003
;
108
(
418
Suppl.418
):
29
33
.
[PubMed]
0065-1591
7.
Bilder
RM
,
Goldman
RS
,
Robinson
D
,
Reiter
G
,
Bell
L
,
Bates
JA
, et al
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates
.
Am J Psychiatry
.
2000
Apr
;
157
(
4
):
549
59
.
[PubMed]
0002-953X
8.
Brüne
M
.
Emotion recognition, ‘theory of mind,’ and social behavior in schizophrenia
.
Psychiatry Res
.
2005
Feb
;
133
(
2-3
):
135
47
.
[PubMed]
0165-1781
9.
Heaton
RK
,
Gladsjo
JA
,
Palmer
BW
,
Kuck
J
,
Marcotte
TD
,
Jeste
DV
.
Stability and course of neuropsychological deficits in schizophrenia
.
Arch Gen Psychiatry
.
2001
Jan
;
58
(
1
):
24
32
.
[PubMed]
0003-990X
10.
Bora
E
,
Yucel
M
,
Pantelis
C
.
Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study
.
Br J Psychiatry
.
2009
Dec
;
195
(
6
):
475
82
.
[PubMed]
0007-1250
11.
Madre
M
,
Canales-Rodríguez
EJ
,
Ortiz-Gil
J
,
Murru
A
,
Torrent
C
,
Bramon
E
, et al
Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review
.
Acta Psychiatr Scand
.
2016
Jul
;
134
(
1
):
16
30
.
[PubMed]
0001-690X
12.
Van Rheenen
TE
,
Bryce
S
,
Tan
EJ
,
Neill
E
,
Gurvich
C
,
Louise
S
, et al
Does cognitive performance map to categorical diagnoses of schizophrenia, schizoaffective disorder and bipolar disorder? A discriminant functions analysis
.
J Affect Disord
.
2016
Mar
;
192
:
109
15
.
[PubMed]
0165-0327
13.
Nuechterlein
KH
,
Green
MF
,
Kern
RS
,
Baade
LE
,
Barch
DM
,
Cohen
JD
, et al
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
.
Am J Psychiatry
.
2008
Feb
;
165
(
2
):
203
13
.
[PubMed]
0002-953X
14.
Peralta
V
,
Cuesta
MJ
.
Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles
.
Actas Luso Esp Neurol Psiquiatr
.
1994
;
22
(
4
):
171
7
.0001-7329
15.
Cárdenas
M
,
Arancibia
H
.
Potencia estadística y cálculo del tamaño del efecto en G*Power: complementos a las pruebas de significación estadística y su aplicación en Psicología
.
Salud Soc
.
2014
;
5
(
2
):
210
24
. 0718-7475
16.
Hill
SK
,
Reilly
JL
,
Keefe
RS
,
Gold
JM
,
Bishop
JR
,
Gershon
ES
, et al
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study
.
Am J Psychiatry
.
2013
Nov
;
170
(
11
):
1275
84
.
[PubMed]
0002-953X
17.
Chen
CK
,
Lee
CY
,
Lee
Y
,
Hung
CF
,
Huang
YC
,
Lee
SY
, et al
Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
Psychiatry Res
.
2018
Aug
;
266
:
79
84
.
[PubMed]
0165-1781
18.
Cella
M
,
Wykes
T
.
Understanding processing speed—its subcomponents and their relationship to characteristics of people with schizophrenia
.
Cogn Neuropsychiatry
.
2013
;
18
(
5
):
437
51
.
[PubMed]
1354-6805
19.
Knowles
EE
,
Weiser
M
,
David
AS
,
Dickinson
D
,
Glahn
D
,
Gold
J
, et al
Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia
.
Schizophr Res
.
2012
Dec
;
142
(
1-3
):
129
36
.
[PubMed]
0920-9964
20.
Morrens
M
,
Hulstijn
W
,
Sabbe
B
.
Psychomotor slowing in schizophrenia
.
Schizophr Bull
.
2007
Jul
;
33
(
4
):
1038
53
.
[PubMed]
0586-7614
21.
Owoso
A
,
Carter
CS
,
Gold
JM
,
MacDonald
AW
 3rd
,
Ragland
JD
,
Silverstein
SM
, et al
Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different
.
Psychol Med
.
2013
Dec
;
43
(
12
):
2535
45
.
[PubMed]
0033-2917
22.
Caponnetto
P
,
Maglia
M
,
Auditore
R
,
Bocchieri
M
,
Caruso
A
,
DiPiazza
J
, et al
Improving neurocognitive functioning in schizophrenia by addition of cognitive remediation therapy to a standard treatment of metacognitive training
.
Ment Illn
.
2018
Dec
;
10
(
2
):
7812
.
[PubMed]
2036-7457
23.
Jäger
M
,
Haack
S
,
Becker
T
,
Frasch
K
.
Schizoaffective disorder—an ongoing challenge for psychiatric nosology
.
Eur Psychiatry
.
2011
Apr
;
26
(
3
):
159
65
.
[PubMed]
0924-9338
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.